XG
XGES.LSE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP
- GBP
No recent price
- Total assets
- 3.44M
- Expense ratio
- 0.29%
- Dividend yield
- -
- 1-year return
- +33.79%
- Holdings
- 99
- Since
- 2022
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does XGES.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (75.4%)
- Largest sector: Healthcare (96.1%)
- Largest region: North America (75.3%)
- Top 3 holdings: 16.5% of the fund
Asset allocation
- US stocks 75.4%
- Non-US stocks 24.8%
- Cash 0.1%
- Bonds 0.0%
Top holdings
- Illumina Inc 6.04%
- Natera Inc 5.64%
- Moderna Inc 4.78%
- Danaher Corporation 4.75%
- Agilent Technologies Inc 4.66%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP performance
Sharpe ratio 0.94- This year
- +27.10%
- 1 year
- +33.79%
- 3 years
- +20.55%
- 5 years
- 0.00%
Volatility 21.0% over 1 year and 17.8% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
XGES.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP top holdings
46.1% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Illumina Inc ILMN.US | Healthcare | United States | 6.04% |
| Natera Inc NTRA.US | Healthcare | United States | 5.64% |
| Moderna Inc MRNA.US | Healthcare | United States | 4.78% |
| Danaher Corporation DHR.US | Healthcare | United States | 4.75% |
| Agilent Technologies Inc A.US | Healthcare | United States | 4.66% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 4.22% |
| GSK plc GSK.US | Healthcare | United States | 4.17% |
| Lonza Group AG LONN.SW | Healthcare | Switzerland | 4.02% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 4.00% |
| Guardant Health Inc GH.US | Healthcare | United States | 3.83% |
The 10 largest of 99 holdings.
XGES.LSE sector exposure
- Healthcare96.1%
- Financial Services0.1%
Share of the stocks in the fund.
XGES.LSE regional exposure
- North America75.3%
- Europe Developed12.4%
- Asia Emerging6.1%
- United Kingdom5.2%
- Australasia0.2%
- Japan0.2%
- Asia Developed0.1%
Share of the stocks in the fund.
Company size
Average market cap 30.2B- Mega cap8.5%
- Big cap21.2%
- Medium cap43.6%
- Small cap23.0%
- Micro cap5.4%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP fund profile
- Fund name
- Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP
- Ticker
- XGES.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Jul 12, 2022
- Trading currency
- GBP
- Expense ratio
- 0.29%